Yang-ling Li

489 total citations
22 papers, 350 citations indexed

About

Yang-ling Li is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Yang-ling Li has authored 22 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Yang-ling Li's work include Cancer therapeutics and mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Research Studies (3 papers). Yang-ling Li is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Research Studies (3 papers). Yang-ling Li collaborates with scholars based in China, United States and Bangladesh. Yang-ling Li's co-authors include Chong Zhang, Lin‐wen Wu, Nengming Lin, Linghui Zeng, Xiu Hu, Bo Yang, Lushan Yu, Qiaojun He, Meidan Ying and Liang Fang and has published in prestigious journals such as Oncogene, Biochemical and Biophysical Research Communications and eLife.

In The Last Decade

Yang-ling Li

19 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang-ling Li China 11 229 102 82 77 42 22 350
Lin‐wen Wu China 12 225 1.0× 82 0.8× 88 1.1× 69 0.9× 31 0.7× 18 381
Gaoyang Zhu China 9 323 1.4× 95 0.9× 115 1.4× 46 0.6× 40 1.0× 14 486
Leiming Wang China 11 274 1.2× 120 1.2× 61 0.7× 57 0.7× 29 0.7× 14 372
Dongdong Luo China 11 219 1.0× 121 1.2× 121 1.5× 67 0.9× 18 0.4× 27 387
Ruoxuan Hei China 7 150 0.7× 55 0.5× 126 1.5× 86 1.1× 22 0.5× 14 292
Janet Mendonca United States 9 379 1.7× 85 0.8× 155 1.9× 109 1.4× 21 0.5× 13 510
Jie Niu China 13 256 1.1× 157 1.5× 90 1.1× 45 0.6× 19 0.5× 19 387
Najah Albadari United States 7 269 1.2× 209 2.0× 119 1.5× 47 0.6× 78 1.9× 16 476
Z. Peter Wang China 14 390 1.7× 128 1.3× 121 1.5× 56 0.7× 19 0.5× 18 524

Countries citing papers authored by Yang-ling Li

Since Specialization
Citations

This map shows the geographic impact of Yang-ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang-ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang-ling Li more than expected).

Fields of papers citing papers by Yang-ling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang-ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang-ling Li. The network helps show where Yang-ling Li may publish in the future.

Co-authorship network of co-authors of Yang-ling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yang-ling Li. A scholar is included among the top collaborators of Yang-ling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang-ling Li. Yang-ling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhang, Man-man, Dongmei Zhang, Quanjun Yang, et al.. (2024). The function and mechanism of LAPTM5 in diseases. Biomedicine & Pharmacotherapy. 178. 117237–117237. 7 indexed citations
4.
Li, Yang-ling, et al.. (2024). Recent research progress of circular RNAs in hepatocellular carcinoma. Frontiers in Oncology. 13. 1192386–1192386. 3 indexed citations
5.
Xu, Lin, Lin‐wen Wu, Jun Deng, et al.. (2023). DSCC1 interacts with HSP90AB1 and promotes the progression of lung adenocarcinoma via regulating ER stress. Cancer Cell International. 23(1). 208–208. 9 indexed citations
6.
Zhang, Jiankang, Zheng Wang, Jie Li, et al.. (2023). Triacanthine enhances the sensitivity of colorectal cancer cells to 5-fluorouracil by regulating RRM2. Phytomedicine. 126. 155204–155204.
7.
Li, Yang-ling, Man-man Zhang, Lin‐wen Wu, et al.. (2022). DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD. Journal of Biomedical Science. 29(1). 34–34. 12 indexed citations
8.
Deng, Jun, Xü Lin, Qi Li, et al.. (2022). Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma. Cancer Cell International. 22(1). 189–189. 3 indexed citations
9.
10.
11.
Li, Yang-ling, et al.. (2020). ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3. Oncogene. 39(39). 6203–6217. 65 indexed citations
12.
Hu, Xiu, Lin‐wen Wu, Linghui Zeng, et al.. (2020). A natural anthraquinone derivative shikonin synergizes with AZD9291 against wtEGFR NSCLC cells through reactive oxygen species-mediated endoplasmic reticulum stress. Phytomedicine. 68. 153189–153189. 15 indexed citations
13.
Qi, Xiaotian, Yang-ling Li, Yanqi Zhang, et al.. (2018). KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells. Acta Pharmacologica Sinica. 40(4). 546–555. 94 indexed citations
14.
Li, Yang-ling, Xiu Hu, Qingyu Li, et al.. (2018). Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapy. Molecular Medicine Reports. 18(4). 3882–3890. 22 indexed citations
15.
Hu, Xiu, et al.. (2018). The anti-tumor effect of regorafenib in lung squamous cell carcinoma in vitro. Biochemical and Biophysical Research Communications. 503(2). 1123–1129. 19 indexed citations
16.
Li, Yang-ling, Xiu Hu, Jialing Chen, et al.. (2018). Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia. Biochemical and Biophysical Research Communications. 498(3). 481–486. 24 indexed citations
17.
Li, Yang-ling, Jiao Sun, Yiming Zhao, et al.. (2016). Evodiamine induces apoptosis and enhances apoptotic effects of erlotinib in wild-type EGFR NSCLC cells via S6K1-mediated Mcl-1 inhibition. Medical Oncology. 33(2). 16–16. 22 indexed citations
18.
Zhang, Dan, Bo Zhang, Lixin Zhou, et al.. (2016). Deacetylisovaltratum disrupts microtubule dynamics and causes G2/M-phase arrest in human gastric cancer cells in vitro. Acta Pharmacologica Sinica. 37(12). 1597–1605. 10 indexed citations
19.
Li, Yang-ling, Jiao Sun, Xiu Hu, et al.. (2016). Epothilone B induces apoptosis and enhances apoptotic effects of ABT-737 on human cancer cells via PI3K/AKT/mTOR pathway. Journal of Cancer Research and Clinical Oncology. 142(11). 2281–2289. 12 indexed citations
20.
Zhang, Chong, et al.. (2016). Nedaplatin enhanced apoptotic effects of ABT-737 in human cancer cells via Mcl-1 inhibition. Oncology Letters. 12(5). 4195–4202. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin‐wen Wu Breakdown of academic impact, for papers by Gaoyang Zhu Breakdown of academic impact, for papers by Leiming Wang Breakdown of academic impact, for papers by Dongdong Luo Breakdown of academic impact, for papers by Ruoxuan Hei Breakdown of academic impact, for papers by Janet Mendonca Breakdown of academic impact, for papers by Jie Niu Breakdown of academic impact, for papers by Najah Albadari Breakdown of academic impact, for papers by Z. Peter Wang
Rankless by CCL
2026